// App-Quantinova.ai

P5-07-05 : BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype in TNBC cells: Implications for breast cancer early lesions

Researchers

Presenter

  • A Sinha

Principal Investigators

  • BT Paul

  • WM ElShamy

Medical Centers

  • University of Mississippi Medical Center Cancer Institute, Jackson, MS

  • University of Connecticut Health Center, Farmington, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Triple-negative breast cancer

Biomarkers

  • Aryl hydrocarbon receptor nuclear translocator-like protein 1

  • Cadherin 3

  • Circulating tumor cells

  • Cluster of Differentiation 44

  • Cytokeratin 17

  • Cytokeratin 5

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • DE-074

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved